The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

53 articles for F Chen


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-Resistant S. aureus (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN).EBI
East China University of Science and Technology
Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections.EBI
East China University of Science and Technology
Discovery of 6-(difluoro(6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazin-3-yl)methyl)quinoline as a highly potent and selective c-Met inhibitor.EBI
Chinese Academy of Sciences (Cas)
Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy.EBI
Shanghai Institute of Materia Medica
Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors.EBI
Chinese National Center For Drug Screening
5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series.EBI
Fudan University
5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.EBI
University of Minnesota
The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.EBI
Chinese Academy of Sciences
Synthesis and biological evaluation of C-12 triazole and oxadiazole analogs of salvinorin A.EBI
Harvard Medical School
Androstene-3,5-dienes as ER-beta selective SERMs.EBI
Merck Research Laboratories
Bridged androstenediol analogs as ER-beta selective SERMs.EBI
Merck Research Laboratories
Androstenediol analogs as ER-beta-selective SERMs.EBI
Merck Research Laboratories
Synthesis of 2',3'-dideoxynucleoside 5'-alpha-P-borano-beta,gamma-(difluoromethylene)triphosphates and their inhibition of HIV-1 reverse transcriptase.EBI
Biota
Studies on gambogic acid (IV): Exploring structure-activity relationship with I¿B kinase-beta (IKKß).EBI
China Pharmaceutical University
Design, synthesis, and biological evaluation of 16-substituted 4-azasteroids as tissue-selective androgen receptor modulators (SARMs).EBI
Merck Research Laboratories
Structure-based screening, optimization and biological evaluation of novel chrysin-based derivatives as selective PPARγ modulators for the treatment of T2DM and hepatic steatosis.EBI
Guangzhou Medical University
Allosteric Activation of Protein Phosphatase 5 with Small Molecules.EBI
China Pharmaceutical University
Design, synthesis and biological evaluation of biaryl amide derivatives against SARS-CoV-2 with dual-target mechanism.EBI
Chinese Academy of Medical Sciences and Peking Union Medical College
Structure Guided Discovery of Novel Pan Metallo-β-Lactamase Inhibitors with Improved Gram-Negative Bacterial Cell Penetration.EBI
Merck & Co.
Design of FK866-Based Degraders for Blocking the Nonenzymatic Functions of Nicotinamide Phosphoribosyltransferase.EBI
Beijing University of Chinese Medicine
Structural modification based on the diclofenac scaffold: Achieving reduced colitis side effects through COX-2/NLRP3 selective inhibition.EBI
Zhejiang University
Discovery of Highly Selective, Potent, Covalent, and Orally Bioavailable Factor XIIa Inhibitors for the Treatment of Thrombo-Inflammation.EBI
Hefei University of Technology
Aporphines: A privileged scaffold in CNS drug discovery.EBI
Soochow University
Synthesis and Anti-Inflammatory Activity of the Natural Cyclooxygenase-2 Inhibitor Axinelline A and Its Analogues.EBI
Zhejiang University
Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure.EBI
University of Maryland
Discovery of HN37 as a Potent and Chemically Stable Antiepileptic Drug Candidate.EBI
Shanghai Institute of Materia Medica
Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.EBI
Chinese Academy of Sciences
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of NaEBI
Merck
Conjugates Derived from Lapatinib Derivatives with Cancer Cell Stemness Inhibitors Effectively Reversed Drug Resistance in Triple-Negative Breast Cancer.EBI
Southeast University
Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.EBI
South China Agricultural University
Discovery of 5-(3-Chlorophenylamino)benzo[EBI
Southeast University
Discovery of Novel c-Mesenchymal-Epithelia transition factor and histone deacetylase dual inhibitors.EBI
Shenyang Pharmaceutical University
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.EBI
Peking University
Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors.EBI
Fudan University
Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains.EBI
Fudan University
Spirostaphylotrichin X from a Marine-Derived Fungus as an Anti-influenza Agent Targeting RNA Polymerase PB2.EBI
Chinese Academy of Sciences
Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.EBI
Fudan University
Synthesis and in Vitro and in Vivo Biological Evaluation of Tissue-Specific Bisthiazole Histone Deacetylase (HDAC) Inhibitors.EBI
Chinese Academy of Sciences
Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles.EBI
Fudan University
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma.EBI
Fuzhou University
Identification of a New RXRα Antagonist Targeting the Coregulator-Binding Site.EBI
Xiamen University
Novel Staphyloxanthin Inhibitors with Improved Potency against Multidrug Resistant EBI
East China University of Science and Technology
Design, synthesis, and evaluation of novel l-phenylglycine derivatives as potential PPARγ lead compounds.EBI
Southwest University
Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.EBI
Fudan University
Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections.EBI
East China University of Science and Technology
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.EBI
East China University of Science and Technology
Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors.EBI
Fudan University
Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.EBI
East China University of Science and Technology
NRF2-ACTIVATING COMPOUNDBDB
Senju Pharmaceutical Co.
Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the sameBDB
Seoul National University Hospital
C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising sameBDB
Green Cross
 
UROKINASE in CSAR_FULL_RELEASE_3JULY2012BDB
Csar